|
1
|
Lyman GH, Culakova E, Poniewierski MS and
Kuderer NM: Morbidity, mortality and costs associated with venous
thromboembolism in hospitalized patients with cancer. Thromb Res.
164 (Suppl 1):S112–S118. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Timp JF, Braekkan SK, Versteeg HH and
Cannegieter SC: Epidemiology of cancer-associated venous
thrombosis. Blood. 122:1712–1723. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tsai AW, Cushman M, Rosamond WD, Heckbert
SR, Polak JF and Folsom AR: Cardiovascular risk factors and venous
thromboembolism incidence: The longitudinal investigation of
thromboembolism etiology. Arch Intern Med. 162:1182–1189.
2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sakuma M, Nakamura M, Yamada N, Ota S,
Shirato K, Nakano T, Ito M and Kobayashi T: Venous thromboembolism:
Deep vein thrombosis with pulmonary embolism, deep vein thrombosis
alone, and pulmonary embolism alone. Circ J. 73:305–309.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Walker AJ, Card TR, West J, Crooks C and
Grainge MJ: Incidence of venous thromboembolism in patients with
cancer-a cohort study using linked United Kingdom databases. Eur J
Cancer. 49:1404–1413. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ashrani AA, Gullerud RE, Petterson TM,
Marks RS, Bailey KR and Heit JA: Risk factors for incident venous
thromboembolism in active cancer patients: A population based
case-control study. Thromb Res. 139:29–37. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Furie B and Furie BC: Mechanisms of
thrombus formation. N Engl J Med. 359:938–949. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Satoh T, Matsumoto K, Tanaka YO, Akiyama
A, Nakao S, Sakurai M, Ochi H, Onuki M, Minaguchi T, Sakurai H and
Yoshikawa H: Incidence of venous thromboembolism before treatment
in cervical cancer and the impact of management on venous
thromboembolism after commencement of treatment. Thromb Res.
131:e127–e132. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Trousseau A: Phlegmasia alba dolens. Clin
Med Hotel-Dieu Paris. 3:654–712. 1865.
|
|
10
|
Nakano F, Matsubara T, Ishigaki T,
Hatazaki S, Mouri G, Nakatsuka Y and Suzuki H: Incidence and risk
factor of deep venous thrombosis in patients undergoing craniotomy
for brain tumors: A Japanese single-center, retrospective study.
Thromb Res. 165:95–100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kekre N and Connors JM: Venous
thromboembolism incidence in hematologic malignancies. Blood Rev.
33:24–32. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Du H, Zhao H, Li M, Ji H, Ren F, Wang P,
Li X, Dong M, Dawar R, Chen G and Chen J: Analysis of the incidence
of lower extremity venous thrombosis and its related risk factors
in admitted patients with lung cancer. Zhongguo Fei Ai Za Zhi.
21:761–766. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
13
|
Osaki T, Saito H, Fukumoto Y, Kono Y,
Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Sato K, Hirooka Y
and Fujiwara Y: Risk and incidence of perioperative deep vein
thrombosis in patients undergoing gastric cancer surgery. Surg
Today. 48:525–533. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen YY, You SL, Chen CA, Shih LY, Koong
SL, Chao KY, Hsiao ML, Hsieh CY and Chen CJ: Taiwan Cervical Cancer
Screening Task Force. Effectiveness of national cervical cancer
screening programme in Taiwan: 12-Year experiences. Br J Cancer.
101:174–177. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Matsuo K, Moeini A, Machida H, Fullerton
ME, Shabalova A, Brunette LL and Roman LD: Significance of venous
thromboembolism in women with cervical cancer. Gynecol Oncol.
142:405–412. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jacobson G, Lammli J, Zamba G, Hua L and
Goodheart MJ: Thromboembolic events in patients with cervical
carcinoma: Incidence and effect on survival. Gynecol Oncol.
113:240–244. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mandalà M, Falanga A and Roila F: ESMO
Guidelines Working Group. Management of venous thromboembolism
(VTE) in cancer patients: ESMO clinical practice guidelines. Ann
Oncol. 22 (Suppl 6):vi85–vi92. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Agnelli G, Bolis G, Capussotti L, Scarpa
RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia
F, et al: A clinical outcome-based prospective study on venous
thromboembolism after cancer surgery: The @RISTOS project. Ann
Surg. 243:89–95. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
FIGO Committee on Gynecologic Oncology.
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynaecol Obstet. 125:97–98. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
World Health Organization (WHO): WHO
international classification of diseases for oncology, 3rd Edition
(ICD-O-3). WHO, Geneva, 2000. https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology.
|
|
22
|
Chen W, Zhang Y, Yang Y, Zhai Z and Wang
C: Prognostic significance of arterial and venous thrombosis in
resected specimens for non-small cell lung cancer. Thromb Res.
136:451–455. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tsai SJ, Ruan YX, Lee CC, Lee MS, Chiou
WY, Lin HY, Hsu FC, Su YC and Hung SK: The incidence of venous
thromboembolism in cervical cancer: A nationwide population-based
study. BMC Res Notes. 5(316)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ailawadi M and Del Priore G: A comparison
of thromboembolic prophylaxis in gynecologic oncology patients. Int
J Gynecol Cancer. 11:354–358. 2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Aschwanden M, Labs KH, Jeanneret C, Gehrig
A and Jaeger KA: The value of rapid D-dimer testing combined with
structured clinical evaluation for the diagnosis of deep vein
thrombosis. J Vasc Surg. 30:929–935. 1999.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Adam SS, Key NS and Greenberg CS: D-dimer
antigen: Current concepts and future prospects. Blood.
113:2878–2887. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Takach Lapner S, Julian JA, Linkins LA,
Bates SM and Kearon C: Questioning the use of an age-adjusted
D-dimer threshold to exclude venous thromboembolism: Analysis of
individual patient data from two diagnostic studies. J Thromb
Haemost. 14:1953–1959. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ay C, Dunkler D, Marosi C, Chiriac AL,
Vormittag R, Simanek R, Quehenberger P, Zielinski C and Pabinger I:
Prediction of venous thromboembolism in cancer patients. Blood.
116:5377–5382. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sartori M, Migliaccio L, Favaretto E, Cini
M, Legnani C, Palareti G and Cosmi B: D-dimer for the diagnosis of
upper extremity deep and superficial venous thrombosis. Thromb Res.
135:673–678. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kawaguchi R, Furukawa N and Kobayashi H:
Cut-off value of D-dimer for prediction of deep venous thrombosis
before treatment in ovarian cancer. J Gynecol Oncol. 23:98–102.
2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Barbera L and Thomas G: Venous
thromboembolism in cervical cancer. Lancet Oncol. 9:54–60.
2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jacobson GM, Kamath RS, Smith BJ and
Goodheart MJ: Thromboembolic events in patients treated with
definitive chemotherapy and radiation therapy for invasive cervical
cancer. Gynecol Oncol. 96:470–474. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kim JY, Khavanin N, Rambachan A, McCarthy
RJ, Mlodinow AS, De Oliveria GS Jr, Stock MC, Gust MJ and Mahvi DM:
Surgical duration and risk of venous thromboembolism. JAMA Surg.
150:110–117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang W, Liu X, Cheng H, Yang Z and Zhang
G: Risk factors and treatment of venous thromboembolism in
perioperative patients with ovarian cancer in China. Medicine
(Baltimore). 97(e11754)2018.PubMed/NCBI View Article : Google Scholar
|
